Increased Quality of Life For many individuals struggling with obesity, losing weight is not just about aesthetics but also about improving overall health and quality of life
Nathalia Souza, a 37-year-old from New Jersey, started taking tirzepatide after three years of dieting and exercising resulted in just 30 pounds of weight loss
Key findings across the STEP trials: Average weight loss of ~15% of body weight roughly 15 kg (33 lbs) for a 100 kg (220 lb) person 87% of patients lost at least 5% of body weight, compared to 31% on placebo Nearly 70% of patients lost at least 10% of body weight About 1 in 3 patients lost 20% or more Weight loss was maintained throughout the treatment period with continued medication use Significant improvements in blood pressure, blood sugar, cholesterol, and inflammatory markers alongside weight loss These results are dramatically better than any prior weight loss medication
This improved comfort may be related to: More balanced hormonal signaling (GLP-1 + GIP) GIP activity that may reduce GLP-1-related nausea Smoother appetite regulation at equivalent weight-loss levels Personalized dosing and slow titration are essential for both medications
C-max decreased by up to 30% while iAUC decreased by up to 56% [2]
